Prime Capital Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,100
Closed -$27.2K 949
2024
Q3
$27.2K Hold
2,100
﹤0.01% 908
2024
Q2
$51.3K Hold
2,100
﹤0.01% 903
2024
Q1
$55.3K Hold
2,100
﹤0.01% 979
2023
Q4
$61.1K Buy
+2,100
New +$986K ﹤0.01% 931

Other funds holding IDXX

Prime Capital Investment Advisors's IDXX Position: Q2 2026 in Review

Prime Capital Investment Advisors increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, buying an estimated $26.4K and bringing the position to 3,952 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #374.

Prime Capital Investment Advisors first reported a position in IDXX in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.61M in Q4 2023. 897 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Prime Capital Investment Advisors held 3,952 shares of Idexx Laboratories worth $2.08M as of Q2 2026.
  • Prime Capital Investment Advisors bought 47 Idexx Laboratories shares in Q2 2026, an estimated $26.4K.
  • Idexx Laboratories made up 0.02% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #374 holding.
  • Prime Capital Investment Advisors first reported a position in Idexx Laboratories in Q4 2018 and has held it in 13 quarters since.
  • Prime Capital Investment Advisors's Idexx Laboratories position peaked at $3.61M in Q4 2023.
  • 897 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.